Cargando…
Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-D(ΔNΔC) gene therapy eight-year follow-up of phase I KAT301 study
In phase I KAT301 trial, intramyocardial adenovirus-mediated vascular endothelial growth factor -D(ΔNΔC) (AdVEGF-D) gene therapy (GT) resulted in a significant improvement in myocardial perfusion reserve and relieved symptoms in refractory angina patients at 1-year follow-up without major safety con...
Autores principales: | Leikas, Aleksi J., Hassinen, Iiro, Hedman, Antti, Kivelä, Antti, Ylä-Herttuala, Seppo, Hartikainen, Juha E. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159942/ https://www.ncbi.nlm.nih.gov/pubmed/34593990 http://dx.doi.org/10.1038/s41434-021-00295-1 |
Ejemplares similares
-
Adenoviral intramyocardial VEGF-D(ΔNΔC) gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up
por: Hartikainen, Juha, et al.
Publicado: (2017) -
Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety
por: Leikas, Aleksi J., et al.
Publicado: (2023) -
Adenoviral VEGF-D(ΔN ΔC) gene therapy for myocardial ischemia
por: Pajula, Juho, et al.
Publicado: (2022) -
Dotted collar placed around carotid artery induces asymmetric neointimal lesion formation in rabbits without intravascular manipulations
por: Kivelä, Antti, et al.
Publicado: (2012) -
Mouse ECG findings in aging, with conduction system affecting drugs and in cardiac pathologies: Development and validation of ECG analysis algorithm in mice
por: Merentie, Mari, et al.
Publicado: (2015)